Conventional small molecule approaches have struggled to address genetic defects and complex disease mechanisms, leaving ...
What we’re doing is working but it’s not good enough,” CEO Philipp Navratil told investors during the CPG major’s Q3 FY25 ...
Discusses Business Transformation Strategy and Plans for Accelerated Growth October 16, 2025 5:00 PM EDTCompany ParticipantsXi-Yong Fu ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, Results from a Phase 3 study ...
From October 17 to 21, the European Society for Medical Oncology (ESMO) Annual Congress convened in Berlin, bringing together global leaders in oncology and pharmaceutical innovation. Representing ...
Musk posted nonstop at the beginning of the year about British politics, until his focus was consumed by DOGE. Now he’s back.
A 35-year-old woman at 20 weeks and 3 days of pregnancy presented to the Tufts Medical Center retina service with complaints ...
M&A favors late-stage assets, obesity deals surge, AI accelerates manufacturing, and policy drives strategic US facility ...
New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for ...